
### [MONDO:0005509](http://purl.obolibrary.org/obo/MONDO_0005509)
**Label:** histiocytoma

**Subclasses:** [MONDO:0003797](http://purl.obolibrary.org/obo/MONDO_0003797) (inflammatory MFH), [MONDO:0003561](http://purl.obolibrary.org/obo/MONDO_0003561) (malignant giant cell tumor of soft parts), [MONDO:0002618](http://purl.obolibrary.org/obo/MONDO_0002618) (malignant fibrous histiocytoma of bone), [MONDO:0012809](http://purl.obolibrary.org/obo/MONDO_0012809) (histiocytoma, Angiomatoid fibrous), [MONDO:0002990](http://purl.obolibrary.org/obo/MONDO_0002990) (benign deep fibrous histiocytoma), [MONDO:0002142](http://purl.obolibrary.org/obo/MONDO_0002142) (malignant fibroxanthoma), [MONDO:0002989](http://purl.obolibrary.org/obo/MONDO_0002989) (benign fibrous histiocytoma), [MONDO:0018153](http://purl.obolibrary.org/obo/MONDO_0018153) (Erdheim-Chester disease), [MONDO:0006717](http://purl.obolibrary.org/obo/MONDO_0006717) (cutaneous fibrous histiocytoma), [MONDO:0010017](http://purl.obolibrary.org/obo/MONDO_0010017) (sea-blue histiocyte syndrome), 

**Mapped go classes:** [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0005874](http://purl.obolibrary.org/obo/GO_0005874) (microtubule), [GO:0000980](http://purl.obolibrary.org/obo/GO_0000980) (RNA polymerase II distal enhancer sequence-specific DNA binding), [GO:1990763](http://purl.obolibrary.org/obo/GO_1990763) (arrestin family protein binding), [GO:0051000](http://purl.obolibrary.org/obo/GO_0051000) (positive regulation of nitric-oxide synthase activity), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0007409](http://purl.obolibrary.org/obo/GO_0007409) (axonogenesis), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0070326](http://purl.obolibrary.org/obo/GO_0070326) (very-low-density lipoprotein particle receptor binding), [GO:0030544](http://purl.obolibrary.org/obo/GO_0030544) (Hsp70 protein binding), [GO:0010033](http://purl.obolibrary.org/obo/GO_0010033) (response to organic substance), [GO:0035035](http://purl.obolibrary.org/obo/GO_0035035) (histone acetyltransferase binding), [GO:0006695](http://purl.obolibrary.org/obo/GO_0006695) (cholesterol biosynthetic process), [GO:0045899](http://purl.obolibrary.org/obo/GO_0045899) (positive regulation of RNA polymerase II transcriptional preinitiation complex assembly), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0005759](http://purl.obolibrary.org/obo/GO_0005759) (mitochondrial matrix), [GO:0010944](http://purl.obolibrary.org/obo/GO_0010944) (negative regulation of transcription by competitive promoter binding), [GO:0071363](http://purl.obolibrary.org/obo/GO_0071363) (cellular response to growth factor stimulus), [GO:0031102](http://purl.obolibrary.org/obo/GO_0031102) (neuron projection regeneration), [GO:0033762](http://purl.obolibrary.org/obo/GO_0033762) (response to glucagon), [GO:0033363](http://purl.obolibrary.org/obo/GO_0033363) (secretory granule organization), [GO:1900273](http://purl.obolibrary.org/obo/GO_1900273) (positive regulation of long-term synaptic potentiation), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0060428](http://purl.obolibrary.org/obo/GO_0060428) (lung epithelium development), [GO:0007595](http://purl.obolibrary.org/obo/GO_0007595) (lactation), [GO:0008289](http://purl.obolibrary.org/obo/GO_0008289) (lipid binding), [GO:0042157](http://purl.obolibrary.org/obo/GO_0042157) (lipoprotein metabolic process), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0042159](http://purl.obolibrary.org/obo/GO_0042159) (lipoprotein catabolic process), [GO:0040018](http://purl.obolibrary.org/obo/GO_0040018) (positive regulation of multicellular organism growth), [GO:0060028](http://purl.obolibrary.org/obo/GO_0060028) (convergent extension involved in axis elongation), [GO:0043524](http://purl.obolibrary.org/obo/GO_0043524) (negative regulation of neuron apoptotic process), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0045672](http://purl.obolibrary.org/obo/GO_0045672) (positive regulation of osteoclast differentiation), [GO:0003705](http://purl.obolibrary.org/obo/GO_0003705) (transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding), [GO:0048145](http://purl.obolibrary.org/obo/GO_0048145) (regulation of fibroblast proliferation), [GO:0010873](http://purl.obolibrary.org/obo/GO_0010873) (positive regulation of cholesterol esterification), [GO:0035497](http://purl.obolibrary.org/obo/GO_0035497) (cAMP response element binding), [GO:0060251](http://purl.obolibrary.org/obo/GO_0060251) (regulation of glial cell proliferation), [GO:0046887](http://purl.obolibrary.org/obo/GO_0046887) (positive regulation of hormone secretion), [GO:0030917](http://purl.obolibrary.org/obo/GO_0030917) (midbrain-hindbrain boundary development), [GO:0001540](http://purl.obolibrary.org/obo/GO_0001540) (amyloid-beta binding), [GO:0046889](http://purl.obolibrary.org/obo/GO_0046889) (positive regulation of lipid biosynthetic process), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0030879](http://purl.obolibrary.org/obo/GO_0030879) (mammary gland development), [GO:0030516](http://purl.obolibrary.org/obo/GO_0030516) (regulation of axon extension), [GO:1990830](http://purl.obolibrary.org/obo/GO_1990830) (cellular response to leukemia inhibitory factor), [GO:0006707](http://purl.obolibrary.org/obo/GO_0006707) (cholesterol catabolic process), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0033344](http://purl.obolibrary.org/obo/GO_0033344) (cholesterol efflux), [GO:0106003](http://purl.obolibrary.org/obo/GO_0106003) (amyloid-beta complex), [GO:0032374](http://purl.obolibrary.org/obo/GO_0032374) (regulation of cholesterol transport), [GO:0034670](http://purl.obolibrary.org/obo/GO_0034670) (chemotaxis to arachidonic acid), [GO:0007179](http://purl.obolibrary.org/obo/GO_0007179) (transforming growth factor beta receptor signaling pathway), [GO:0006366](http://purl.obolibrary.org/obo/GO_0006366) (transcription by RNA polymerase II), [GO:0045600](http://purl.obolibrary.org/obo/GO_0045600) (positive regulation of fat cell differentiation), [GO:0008542](http://purl.obolibrary.org/obo/GO_0008542) (visual learning), [GO:0001225](http://purl.obolibrary.org/obo/GO_0001225) (RNA polymerase II transcription coactivator binding), [GO:0007613](http://purl.obolibrary.org/obo/GO_0007613) (memory), [GO:0001102](http://purl.obolibrary.org/obo/GO_0001102) (RNA polymerase II activating transcription factor binding), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0071294](http://purl.obolibrary.org/obo/GO_0071294) (cellular response to zinc ion), [GO:0050750](http://purl.obolibrary.org/obo/GO_0050750) (low-density lipoprotein particle receptor binding), [GO:0001190](http://purl.obolibrary.org/obo/GO_0001190) (transcriptional activator activity, RNA polymerase II transcription factor binding), [GO:0060430](http://purl.obolibrary.org/obo/GO_0060430) (lung saccule development), [GO:0042627](http://purl.obolibrary.org/obo/GO_0042627) (chylomicron), [GO:0034380](http://purl.obolibrary.org/obo/GO_0034380) (high-density lipoprotein particle assembly), [GO:0015485](http://purl.obolibrary.org/obo/GO_0015485) (cholesterol binding), [GO:1900221](http://purl.obolibrary.org/obo/GO_1900221) (regulation of amyloid-beta clearance), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0007623](http://purl.obolibrary.org/obo/GO_0007623) (circadian rhythm), [GO:0000785](http://purl.obolibrary.org/obo/GO_0000785) (chromatin), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0021983](http://purl.obolibrary.org/obo/GO_0021983) (pituitary gland development), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0001756](http://purl.obolibrary.org/obo/GO_0001756) (somitogenesis), [GO:0032916](http://purl.obolibrary.org/obo/GO_0032916) (positive regulation of transforming growth factor beta3 production), [GO:0005719](http://purl.obolibrary.org/obo/GO_0005719) (nuclear euchromatin), [GO:0019433](http://purl.obolibrary.org/obo/GO_0019433) (triglyceride catabolic process), [GO:0034372](http://purl.obolibrary.org/obo/GO_0034372) (very-low-density lipoprotein particle remodeling), [GO:0008361](http://purl.obolibrary.org/obo/GO_0008361) (regulation of cell size), [GO:0060228](http://purl.obolibrary.org/obo/GO_0060228) (phosphatidylcholine-sterol O-acyltransferase activator activity), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0042752](http://purl.obolibrary.org/obo/GO_0042752) (regulation of circadian rhythm), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0042632](http://purl.obolibrary.org/obo/GO_0042632) (cholesterol homeostasis), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0005769](http://purl.obolibrary.org/obo/GO_0005769) (early endosome), [GO:0043691](http://purl.obolibrary.org/obo/GO_0043691) (reverse cholesterol transport), [GO:1990589](http://purl.obolibrary.org/obo/GO_1990589) (ATF4-CREB1 transcription factor complex), [GO:0060509](http://purl.obolibrary.org/obo/GO_0060509) (Type I pneumocyte differentiation), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:0055025](http://purl.obolibrary.org/obo/GO_0055025) (positive regulation of cardiac muscle tissue development), [GO:0017127](http://purl.obolibrary.org/obo/GO_0017127) (cholesterol transporter activity), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0034364](http://purl.obolibrary.org/obo/GO_0034364) (high-density lipoprotein particle), [GO:0034363](http://purl.obolibrary.org/obo/GO_0034363) (intermediate-density lipoprotein particle), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:1901215](http://purl.obolibrary.org/obo/GO_1901215) (negative regulation of neuron death), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0005543](http://purl.obolibrary.org/obo/GO_0005543) (phospholipid binding), [GO:0006869](http://purl.obolibrary.org/obo/GO_0006869) (lipid transport), [GO:0048511](http://purl.obolibrary.org/obo/GO_0048511) (rhythmic process), [GO:0042493](http://purl.obolibrary.org/obo/GO_0042493) (response to drug), [GO:0035729](http://purl.obolibrary.org/obo/GO_0035729) (cellular response to hepatocyte growth factor stimulus), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0050821](http://purl.obolibrary.org/obo/GO_0050821) (protein stabilization), [GO:0033700](http://purl.obolibrary.org/obo/GO_0033700) (phospholipid efflux), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), 

**Class expressions from DL-Learner:**

- Thing 54.43%
- [GO:1990589](http://purl.obolibrary.org/obo/GO_1990589) (ATF4-CREB1 transcription factor complex) 51.04%
- [GO:0034363](http://purl.obolibrary.org/obo/GO_0034363) (intermediate-density lipoprotein particle) 51.04%
- [GO:0005759](http://purl.obolibrary.org/obo/GO_0005759) (mitochondrial matrix) 51.04%
- [GO:0005719](http://purl.obolibrary.org/obo/GO_0005719) (nuclear euchromatin) 51.04%
- [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm) 51.04%
- [GO:0000791](http://purl.obolibrary.org/obo/GO_0000791) (euchromatin) 51.04%
- [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin) and [GO:0000791](http://purl.obolibrary.org/obo/GO_0000791) (euchromatin) 51.04%
- [GO:0034385](http://purl.obolibrary.org/obo/GO_0034385) (triglyceride-rich plasma lipoprotein particle) 36.40%
- [GO:0034385](http://purl.obolibrary.org/obo/GO_0034385) (triglyceride-rich plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 36.40%
- [GO:0034385](http://purl.obolibrary.org/obo/GO_0034385) (triglyceride-rich plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 36.40%
- [GO:0034385](http://purl.obolibrary.org/obo/GO_0034385) (triglyceride-rich plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 36.40%
- [GO:0034385](http://purl.obolibrary.org/obo/GO_0034385) (triglyceride-rich plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 36.40%
- [GO:0034385](http://purl.obolibrary.org/obo/GO_0034385) (triglyceride-rich plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 36.40%
- [GO:0034385](http://purl.obolibrary.org/obo/GO_0034385) (triglyceride-rich plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 36.40%


